United States · Series A startup

Who invested in Flume Health

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Financial Services

Funding summaryUpdated 26 Oct 2026

$30Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $30MMar 2022
Investors
5
See who backed them

The rounds

  1. Mar 2022
    Series A$30M

    Source recordedSEC filing: $30M sold, first sale Jan 2022

Founders and team

From Flume Health's own website and the SEC filings it signed: 1 founder, 2 on the team.

Cedric Kovacs-JohnsonFounder & Chief Executive OfficerNamed on its 2022 Form D
  • Casey HancockChief Technology Officer
  • Will CoursenChief Deployment Officer

On the board, as filediGabby ControJon Sklaroff

Everyone who backed them

Bossa InvestVC firm1round
Founder CollectiveVC firm1round
Crosslink CapitalVC firm1round
Optum VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Flume Health

Who invested in Flume Health?

Flume Health's investors include Bossa Invest, Founder Collective, Crosslink Capital, Primary Venture Partners and Optum Ventures.

How much has Flume Health raised?

Flume Health has raised $30M across 1 round since 2022.

When did Flume Health last raise?

Flume Health's most recent round was a Series A of $30M in Mar 2022.

What was Flume Health's biggest round?

Its most recent round, $30M in Mar 2022, is also its largest on record.

Who backed Flume Health first?

Flume Health's first round on record, in Mar 2022, was backed by Bossa Invest, Founder Collective and Crosslink Capital and 2 others.

What stage is Flume Health at?

Flume Health's latest named round is a Series A, in Mar 2022.

Where is Flume Health based?

Flume Health is based in the United States.

Companies like Flume Health

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.